Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GLP-1 Agonists Before Total Hip and Knee Arthroplasty
NCT07755085Phase 4Not yet recruiting
- Sponsor
- Nova Scotia Health
- Start
- Oct 2026
- Primary completion
- Jun 2028
- Countries
- 1
01
Overview
A Phase 4 trial of semaglutide in obesity, arthritis, sponsored by Nova Scotia Health. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
03
Conditions
obesityarthritis
Beyond the preview
Go deeper on NCT07755085.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07755085.